Prostate-specific Antigen Bounce After Prostate Brachytherapy: Review of a Confusing Phenomenon

被引：58

作者：

Caloglu, Murat ^{[1
]}

Ciezki, Jay

机构：

[1] Trakya Univ, Fac Med, Dept Radiat Oncol, TR-22030 Edirne, Turkey

来源：

UROLOGY | 2009年 / 74卷 / 06期

关键词：

EXTERNAL-BEAM RADIATION; PSA BOUNCE; ANDROGEN DEPRIVATION; SEED IMPLANTATION; PATIENT AGE; SIMULTANEOUS IRRADIATION; FOLLOW-UP; LOW-RISK; CANCER; RADIOTHERAPY;

D O I：

10.1016/j.urology.2009.01.043

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Prostate brachytherapy is a commonly used modality for the treatment of prostate cancer. After prostate brachytherapy, the prostate-specific antigen (PSA) level may fluctuate and increase temporarily without a clear reason in 30-40% of successfully treated men. This phenomenon is called "PSA bounce" and engenders anxiety on the part of the patient and physician. Having reviewed the literature we found 19 articles and summarized in the current review to delineate the facts of this relatively common and ambiguous phenomenon. Although several patient and treatment related factors were assessed by studies, only age remained as the most consistent predictor. UROLOGY 74: 1183-1190, 2009. (C) 2009 Elsevier Inc.

引用

页码：1183 / 1190

页数：8

共 39 条

[1]

ABEL L, 2007, UROL NURS, V27, P518

[2]

ABEL L, 2007, UROL NURS, V27, P511

[3]

Abel Laurie, 2007, Urol Nurs, V27, P507

[4] PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone [J].

Akyol, F ;

Ozyigit, G ;

Selek, U ;

Karabulut, E .

EUROPEAN UROLOGY, 2005, 48 (01) :40-45

[5] Isotope and patient age predict for PSA spikes after permanent prostate brachytherapy [J].

Bostancic, Chelsea ;

Merrick, Gregory S. ;

Butler, Wayne M. ;

Wallner, Kent E. ;

Allen, Zachariah ;

Galbreath, Robert ;

Lief, Jonathan ;

Gutman, Sarah E. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (05) :1431-1437

[6]

Cavanagh W, 2000, Semin Urol Oncol, V18, P160

[7] Urinary symptom flare following I-125 prostate brachytherapy [J].

Cesaretti, JA ;

Stone, NN ;

Stock, RG .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (04) :1085-1092

[8] PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time [J].

Ciezki, JP ;

Reddy, CA ;

Garcia, J ;

Angermeier, K ;

Ulchaker, J ;

Mahadevan, A ;

Chehade, N ;

Altman, A ;

Klein, EA .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02) :512-517

[9] A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy [J].

Ciezki, JP ;

Klein, EA ;

Angermeier, K ;

Ulchaker, J ;

Chehade, N ;

Altman, A ;

Mahadevan, A ;

Reddy, CA .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (05) :1347-1350

[10] The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management [J].

Cooperberg, MR ;

Lubeck, DP ;

Meni, MV ;

Mehta, SS ;

Carroll, PR .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2141-2149

← 1 2 3 4 →